Pyrazine derivatives: a patent review (2008 – present)

Author： Ferreira Sabrina Baptista   Kaiser Carlos Roland  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.9, 2012-09, pp. : 1033-1051

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors: a patent review (2008 – present)

By Pohanka Miroslav  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 8, 2012-08 ,pp. : 871-886

Informa Healthcare

Access to resources Recommend Favorite

Coumarin-based drugs: a patent review (2008 – present)

By Kontogiorgis Christos   Detsi Anastasia   Hadjipavlou-Litina Dimitra  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 437-454

Informa Healthcare

Access to resources Recommend Favorite

Quinoxaline derivatives: a patent review (2006 – present)

By González Mercedes   Cerecetto Hugo  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1289-1302

Informa Healthcare

Access to resources Recommend Favorite

Artemisinin derivatives: a patent review (2006 – present)

By Njuguna Nicholas M   Ongarora Dennis S B   Chibale Kelly  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1179-1203

Informa Healthcare

Access to resources Recommend Favorite

Imidazoline derivatives: a patent review (2006 – present)

By Guan Xianghong   Hu Yongzhou  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1353-1365

Informa Healthcare

Access to resources Recommend Favorite